Patients’ clinical and histological characteristics
| PCa (%) | BPH (%) | |
|---|---|---|
| BPH, benign prostate hyperplasia; PCa, prostate cancer; PSA, prostate specific antigen. | ||
| Cases | 33 | 24 |
| Mean (SD) age in years | 64.7 (3.9) | 66.1 (4.4) |
| TNM | ||
| T1 | 2 (6.1) | |
| T2 | 14 (42.4) | |
| T3 | 17 (51.5) | |
| Gleason score | ||
| 2–4 | 7 (21.2) | |
| 5–7 | 15 (45.5) | |
| 8–10 | 11 (33.3) | |
| Mean (SD) PSA (ng/ml) | ||
| <4.0 | 3 (9.1) | 9 (37.5) |
| 4.0–10.0 | 6 (18.2) | 12 (50.0) |
| >10.0 | 24 (72.7) | 3 (12.5) |